Reviva Pharmaceuticals Holdings RVPH

$ 1.34 -10.67%

Quarterly report 2024-Q3
added 11-14-2024

Reviva Pharmaceuticals Holdings Balance Sheet 2011-2024 | RVPH

Annual Balance Sheet Reviva Pharmaceuticals Holdings

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-8.76 M	3.76 M	-	-	-	-	-	-	-	-
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	17.2 M	9.96 M	2.34 M	300 K	23 K	-	-	-	-	-	-	-	-
Total Liabilities	18 M	10.5 M	2.72 M	1.33 M	6.81 M	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-134 M	-95.1 M	-66.8 M	-	-54.5 M	-	-	-	-	-	-	-	-
Total Assets	23.7 M	18.9 M	31.4 M	8.76 M	2.6 K	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	23.4 M	18.5 M	29.7 M	8.76 M	193	-	-	-	-	-	-	-	-
Book Value	5.72 M	8.39 M	28.7 M	7.43 M	-6.81 M	-	-	-	-	-	-	-	-
Total Shareholders Equity	5.72 M	8.39 M	28.7 M	5.47 M	-6.81 M	-5.96 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Reviva Pharmaceuticals Holdings

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	17.6 M	14.1 M	14.8 M	18 M	13.9 M	10.2 M	7.12 M	6.61 M	3.68 M	4.58 M	3.91 M	2.72 M	1.62 M	2.01 M	2.14 M	3.3 M	3.3 M	3.3 M	3.3 M	6.81 M	2.25 M	2.24 M	2.24 M	2.24 M	2.22 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-158 M	-150 M	-142 M	-134 M	-121 M	-110 M	-97.8 M	-91.2 M	-83.1 M	-79.5 M	-74.2 M	-66.8 M	-63.1 M	-60.9 M	-59.3 M	-58.3 M	-58.3 M	-58.3 M	-58.3 M	-54.5 M	1.19 M	913 K	574 K	268 K	4.35 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	7.63 M	8.05 M	13.5 M	23.7 M	5.39 M	11.8 M	12.9 M	18.9 M	24 M	20.6 M	25.3 M	31.4 M	33.9 M	36.5 M	6.66 M	8.76 M	8.76 M	8.76 M	8.76 M	2.6 K	66.3 M	66 M	65.6 M	65.3 M	65.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	5.56 M	6.18 M	12 M	23.4 M	4.97 M	11.2 M	11.3 M	18.5 M	23.2 M	19.4 M	23.4 M	29.7 M	33.5 M	35.8 M	5.64 M	8.76 M	8.76 M	8.76 M	8.76 M	193	211 K	274 K	313 K	401 K	211 K	442 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-9.98 M	-6.04 M	-1.35 M	5.72 M	-8.52 M	1.62 M	5.78 M	12.3 M	20.4 M	16.1 M	21.4 M	28.7 M	32.3 M	34.5 M	4.52 M	5.47 M	5.47 M	5.47 M	5.47 M	-6.81 M	64 M	63.7 M	63.4 M	63.1 M	62.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-9.98 M	-6.04 M	-1.35 M	5.72 M	-12.8 M	-1.82 M	1.61 M	12.3 M	20.4 M	16.1 M	21.4 M	28.7 M	32.3 M	34.5 M	4.52 M	5.47 M	5.47 M	5.47 M	5.47 M	-6.81 M	5 M	5 M	5 M	-5.96 M	5 M	5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency